2019 Year End Appeal
With your generosity, we were able to unlock the Matching for a Cure $20,000 donation in memory of Michael Goldberg - bringing the 2019 Annual Appeal campaign total to $107,000!
Before Rolfe Foundation was founded, there were only a handful of researchers in the country devoted to fighting pancreatic cancer. Today, there are thousands of committed experts invested in this cause and we owe this progress to your unwavering support throughout the years!
We are at a critical time and your dollars are crucial in funding further projects so we can SAVE LIVES. Thank you for your contirbution.
Highlighted are a few of the groundbreaking projects YOU have helped support over the years:
- CancerSEEK – Funding the next phase for CancerSEEK, led by Dr. Bert Vogelstein, will further advance and commercialize the liquid biopsy test designed to detect pancreatic cancer at an earlier stage. (Johns Hopkins)
- Epigenetic Patterns – By studying epigenetic patterns on DNA, Dr. Chuan He can begin to develop blood tests to monitor patients who are at risk for pancreatic cancer. If diagnosed, the epigenetic test would provide physicians with valuable prognostic information to select the best therapies for patients. (University of Chicago)
- Pancreatic Cancer Biomarkers – Dr. Ralph Hruban and his team are developing a method to culture precancer lesions in three-dimensions, providing a critical system to study pancreatic precancers. Identifying precursor lesions before they become incurable invasive cancer is key to early detection. (Johns Hopkins)
We all know that early detection makes the difference between life and death. Although pancreatic cancer research is moving at a relatively record pace, we still need more funding to sustain this incredible momentum. This is why your doantion and future contributions matter in the fight against pancreatic cancer.
Thank you for supporting our 2019 Year End Appeal.